Suppr超能文献

鉴定和表征特异性结合 Tau 蛋白磷酸化表位的 DNA 适体。

Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein.

机构信息

Department of Chemistry, Department of Physiology and Functional Genomics, Center for Research at Bio/Nano Interface, UF Health Cancer Center , UF Genetics Institute and McKnight Brain Institute, University of Florida , Gainesville , Florida 32611-7200 , United States.

Department of Emergency Medicine, Department of Chemistry, Department of Neuroscience, and Department of Psychiatry , McKnight Brain Institute, University of Florida , Gainesville , Florida 32611 , United States.

出版信息

J Am Chem Soc. 2018 Oct 31;140(43):14314-14323. doi: 10.1021/jacs.8b08645. Epub 2018 Oct 16.

Abstract

Tau proteins are proteins that stabilize microtubules, but their hyperphosphorylation can result in the formation of protein aggregates and, over time, neurodegeneration. This phenomenon, termed tauopathy, is pathologically involved in several neurodegenerative disorders. DNA aptamers are single-stranded oligonucleotides capable of specific binding to target molecules. Using tau epitopes predisposed for phosphorylation, we identified six distinct aptamers that bind to tau at two phosphorylatable epitopes (Thr-231 and Ser-202) and to full-length Tau441 proteins with nanomolar affinity. In addition, several of these aptamers also inhibit tau phosphorylation (IT4, IT5, IT6) and tau oligomerization (IT3, IT4, IT5, IT6). This is the first report to identify tau epitope-specific aptamers. Such tau aptamers can be used to detect tau in biofluids and uncover the mechanism of tauopathy. They can be further developed into novel therapeutic agents in mitigating tauopathy-associated neurodegenerative disorders.

摘要

tau 蛋白是稳定微管的蛋白质,但它们的过度磷酸化会导致蛋白质聚集的形成,随着时间的推移,还会导致神经退行性变。这种现象被称为 tau 病,与几种神经退行性疾病的病理有关。DNA 适体是能够与靶分子特异性结合的单链寡核苷酸。使用易发生磷酸化的 tau 表位,我们鉴定出六个不同的适体,它们与 tau 在两个可磷酸化表位(Thr-231 和 Ser-202)结合,并与全长 Tau441 蛋白以纳摩尔亲和力结合。此外,这些适体中的几个还可以抑制 tau 磷酸化(IT4、IT5、IT6)和 tau 寡聚化(IT3、IT4、IT5、IT6)。这是首次报道鉴定 tau 表位特异性适体。这种 tau 适体可用于检测生物流体中的 tau,并揭示 tau 病的机制。它们可以进一步开发成减轻与 tau 病相关的神经退行性疾病的新型治疗剂。

相似文献

1
Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein.
J Am Chem Soc. 2018 Oct 31;140(43):14314-14323. doi: 10.1021/jacs.8b08645. Epub 2018 Oct 16.
2
Functional Selection of Tau Oligomerization-Inhibiting Aptamers.
Angew Chem Int Ed Engl. 2024 Apr 24;63(18):e202402007. doi: 10.1002/anie.202402007. Epub 2024 Mar 14.
3
Inhibitory RNA Aptamers of Tau Oligomerization and Their Neuroprotective Roles against Proteotoxic Stress.
Mol Pharm. 2016 Jun 6;13(6):2039-48. doi: 10.1021/acs.molpharmaceut.6b00165. Epub 2016 May 4.
4
A dip-and-read optical aptasensor for detection of tau protein.
Anal Bioanal Chem. 2020 Feb;412(5):1193-1201. doi: 10.1007/s00216-019-02350-8. Epub 2020 Jan 3.
5
Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5384-8. doi: 10.1073/pnas.89.12.5384.
7
Designing antibodies against LRRK2-targeted tau epitopes.
PLoS One. 2018 Sep 27;13(9):e0204367. doi: 10.1371/journal.pone.0204367. eCollection 2018.
8
Methods for Improving Aptamer Binding Affinity.
Molecules. 2016 Mar 28;21(4):421. doi: 10.3390/molecules21040421.
9
Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
Arch Biochem Biophys. 1998 Sep 15;357(2):299-309. doi: 10.1006/abbi.1998.0813.

引用本文的文献

3
Aptamer and N-Degron Ensemble (AptaGron) as a Target Protein Degradation Strategy.
ACS Chem Biol. 2024 Dec 20;19(12):2462-2468. doi: 10.1021/acschembio.4c00536. Epub 2024 Dec 4.
5
Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development.
Molecules. 2024 Mar 2;29(5):1124. doi: 10.3390/molecules29051124.
6
Development of a DNA aptamer targeting IDO1 with anti-tumor effects.
iScience. 2023 Jul 13;26(8):107367. doi: 10.1016/j.isci.2023.107367. eCollection 2023 Aug 18.
7
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics.
Genes Dis. 2022 Aug 23;10(3):960-989. doi: 10.1016/j.gendis.2022.07.023. eCollection 2023 May.
8
Liquid Biopsies, Novel Approaches and Future Directions.
Cancers (Basel). 2023 Mar 3;15(5):1579. doi: 10.3390/cancers15051579.
9
Preparation, applications, and challenges of functional DNA nanomaterials.
Nano Res. 2023;16(3):3895-3912. doi: 10.1007/s12274-022-4793-5. Epub 2022 Aug 31.

本文引用的文献

1
An update on diagnostic and prognostic biomarkers for traumatic brain injury.
Expert Rev Mol Diagn. 2018 Feb;18(2):165-180. doi: 10.1080/14737159.2018.1428089. Epub 2018 Jan 23.
3
Tau-based therapies in neurodegeneration: opportunities and challenges.
Nat Rev Drug Discov. 2017 Dec;16(12):863-883. doi: 10.1038/nrd.2017.155. Epub 2017 Oct 6.
4
FDA-Approved Oligonucleotide Therapies in 2017.
Mol Ther. 2017 May 3;25(5):1069-1075. doi: 10.1016/j.ymthe.2017.03.023. Epub 2017 Mar 31.
5
A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
Sci Rep. 2017 Mar 13;7:44102. doi: 10.1038/srep44102.
7
Rapid and Label-Free Strategy to Isolate Aptamers for Metal Ions.
ACS Nano. 2016 Aug 23;10(8):7558-65. doi: 10.1021/acsnano.6b02558. Epub 2016 Jul 11.
8
Inhibitory RNA Aptamers of Tau Oligomerization and Their Neuroprotective Roles against Proteotoxic Stress.
Mol Pharm. 2016 Jun 6;13(6):2039-48. doi: 10.1021/acs.molpharmaceut.6b00165. Epub 2016 May 4.
9
The Abundance of Nonphosphorylated Tau in Mouse and Human Tauopathy Brains Revealed by the Use of Phos-Tag Method.
Am J Pathol. 2016 Feb;186(2):398-409. doi: 10.1016/j.ajpath.2015.10.009. Epub 2015 Dec 11.
10
The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation.
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):10002-7. doi: 10.1073/pnas.1502159112. Epub 2015 Jul 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验